Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), bought 8,891 shares at $13.27 ($118K) on 2018-08-17, disclosed to the SEC on 2018-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.27 | 4,800 | $64K | 54.1% |
| 2 | $13.21 | 1,301 | $17K | 14.6% |
| 3 | $13.20 | 2,790 | $37K | 31.3% |
| Total | $13.24 avg | 8,891 | $118K | 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |